Menu

In the News

September 8, 2020 • Featured

Walk to End Alzheimer’s Represents a Sea of Personal Stories

GAP-Net site Cleveland Clinic is hosting the Cleveland Walk to End Alzheimer’s on October 4, 2020. Guest columnist Caroline James is the Business Development Specialist at Independence Village & StoryPoint Avon Lake and Retention Chair for the Cleveland Walk to End Alzheimer’s. I’ve worked in senior care for seven years, often helping those with dementia or Alzheimer’s […]

September 2, 2020 • Featured

Clinical Trial Practitioners Key to Jumpstarting Alzheimer’s Research Efforts

GAP President John Dwyer was featured in ACRP about what clinical trials need to be doing to increase awareness and hasten treatments. The clinical trial industry continues to grapple with finding new and more effective ways to expand its efforts to combat Alzheimer’s. The obstacles are real. Alzheimer’s trials cost more per patient than trials […]

September 2, 2020 • In the News

Aducanumab: Will this antibody open new pathways to treating Alzheimer’s?

Citizen Scientist nominee, Florida State Representative Matt Willhite, from GAP-Net site JEM Research Institute, speaks about his mother’s Alzheimer’s diagnosis and involvement in Biogen’s clinical trial. Surprise and skepticism greeted the Biogen company’s announcement that clinical trials of an antibody called aducanumab were resuming this year. Not only that, Biogen asked the federal Food and […]

August 31, 2020 • Featured

An Alzheimer’s Quest: Enrolling More Black People in Clinical Trials

GAP President, John Dwyer, was featured in a Wall Street Journal article on the importance of Black, African-American, Hispanic and Latinx communities being aware of and enrolling in Alzheimer’s clinical trials, and what GAP is doing to help. Brian Van Buren applied to five Alzheimer’s disease clinical trials after being diagnosed with mild cognitive impairment […]

August 20, 2020 • Press Releases

USC Schaeffer Center Report Insightfully Diagnoses Barriers Facing Alzheimer’s Clinical Trials

GAP’s statement: Study cites limited awareness among patients and physicians, anxiety, and lack of quick diagnostics Washington, DC (August 20, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding a University of Southern California Louis D. Schaeffer Center for Health Policy & Economics white paper, “Key Barriers to […]

August 14, 2020 • In the News

Alzheimer’s Research Impacted by COVID-19

GAP-Net site, Syrentis Clinical Research, and GAP President, John Dwyer, were interviewed about the difficulties of recruiting Alzheimer’s clinical trial volunteers in the time of COVID-19, and why their involvement is important. Alzheimer’s disease researchers fear that fewer volunteers and delayed studies due to COVID-19 may hinder the discovery of important treatments for the illness. […]

August 6, 2020 • In the News

Top Doctors 2020

GAP-Net site, Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, was included in the KNPR Top Doctors in Southern Nevada of 2020. How the Top Doctors are selected Castle Connolly Top Doctors is a healthcare research company and the official source for Top Doctors for the past 25 years. Castle Connolly’s established nomination […]

July 30, 2020 • In the News

New Findings from AAIC Indicated Brain-Gut Axis to be the New Breakthrough in the Research Field of Alzheimer’s Disease

GAP-Net Site Lou Ruvo Center for Brain Health at Cleveland Clinic Las Vegas was quoted about how microbiomes in the gut can affect the brain and lead to Alzheimer’s disease. SHANGHAI, July 29, 2020 /PRNewswire/ — Alzheimer’s disease has been an unsolved puzzle for scientists since the first patient was found over 100 years ago. Different theories […]

July 30, 2020 • Press Releases

Global Alzheimer’s Platform Foundation Issues Statement on Recent Groundbreaking Advances in Alzheimer’s Blood Tests

Washington D.C. (July 30, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding recent groundbreaking advances in Alzheimer’s blood test research: “I want to congratulate and thank Dr. Barthélemy, Dr. Horie, Dr. Sato, Dr. Bateman, Dr. Palmqvist, Dr. Janelidze, and Dr. Quiroz on their published research on two […]

July 28, 2020 • In the News

‘Amazing, Isn’t It?’ Long Sought Blood Test for Alzheimer’s in Reach

GAP-Net site Washington University in St. Louis helped develop one of the tests that has diagnosed the disease as accurately as methods that are far more expensive or invasive. Banner Alzheimer’s Institute was also mentioned as a senior author. A newly developed blood test for Alzheimer’s has diagnosed the disease as accurately as methods that […]